Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

1.75
-0.0300-1.69%
Post-market: 1.770.0195+1.11%19:59 EDT
Volume:4.18M
Turnover:7.39M
Market Cap:65.49M
PE:-1.19
High:1.84
Open:1.81
Low:1.73
Close:1.78
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:0.46
T/O Rate:23.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.58
PE(LYR):-1.30

Loading ...

Tenax Therapeutics Names New CFO to Support Growth

TIPRANKS
·
Apr 22

Tenax Therapeutics announces annual shareholder meeting

Reuters
·
Apr 22

Tenax Therapeutics names Thomas R. Staab CFO, replacing interim CFO Thomas McGauley

Reuters
·
Apr 22

Tenax Therapeutics Inc - Thomas R. Staab, Ii Replaces Thomas Mcgauley as CFO

THOMSON REUTERS
·
Apr 22

Tenax Therapeutics Appoints Thomas R. Staab, Ii as Chief Financial Officer

THOMSON REUTERS
·
Apr 22

Press Release: Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

Dow Jones
·
Apr 22

Tenex.ai Raises $250 Million in Funding Round Reportedly Valuing Company at $1 Billion

MT Newswires Live
·
Mar 31

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and Tenax Therapeutics (TENX)

TIPRANKS
·
Mar 30

Tenax Therapeutics Files $300 Million Mixed Shelf

MT Newswires Live
·
Mar 25

Tenax Therapeutics files $300M mixed securities shelf

TIPRANKS
·
Mar 24

Tenax Therapeutics Inc - May Offer up to $300 Mln of Securities - SEC Filing

THOMSON REUTERS
·
Mar 24

Tenax Therapeutics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Mar 17

Cantor starts Tenax at Overweight into Phase 3 readout

TIPRANKS
·
Mar 17

Cantor Fitzgerald Initiates Tenax Therapeutics at Overweight With $35 Price Target

MT Newswires Live
·
Mar 17

Tenax Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 16

Tenax Therapeutics price target raised to $34 from $25 at Guggenheim

TIPRANKS
·
Mar 16

Roth MKM Keeps Their Buy Rating on Tenax Therapeutics (TENX)

TIPRANKS
·
Mar 11

Tenax Therapeutics Q4 EPS $(0.38) Beats $(0.41) Estimate

Benzinga Earnings
·
Mar 10

Tenax Therapeutics FY 2025 net loss rises 199% to USD 52.6 million

Reuters
·
Mar 10

BRIEF-Tenax Therapeutics Q4 Net Income USD -15.54 Million

Reuters
·
Mar 10